Le Lézard
Classified in: Health
Subject: PER

Kelly Hover Joins MedCerts as Executive Vice President of Operations and Student Engagement


DETROIT, Jan. 16, 2020 /PRNewswire/ -- MedCerts, one of the nation's leading providers of online career certification training, announces today the addition of Kelly Hover, former University of Phoenix Director, to its executive team.

Hover will assume the role of Executive Vice President of Operations and Student Engagement, a new position created to maximize MedCerts continued focus on outcomes and employer relations.

"I'm in love with the mission of MedCerts and how the company executes. I've been in higher education for 11 years and no one else has solved the problem of placement," Hover said. "MedCerts has a strategy for that and that's why students are coming to them. The company is not just focused on exam prep or pass rates ? MedCerts is a disruptor in the industry, and I am excited to contribute to that."

Previously, Hover acted as Senior Director of Strategy and Customer Experience for the University of Phoenix, where she redesigned their customer service model to better align with its partners and students and created an omnichannel communication strategy. Hover brings a decade of experience in higher education to MedCerts and is relocating to the metro Detroit area from Phoenix for the role.

"We are excited to announce that Kelly will be joining MedCerts," Jason Aubrey, MedCerts CEO, said. "Her experience directly aligns with our continued efforts to be a pioneer in the world of online education and meet the needs of our students, the healthcare industry and our partners."

MedCerts has been focusing efforts on improving efficiencies for students in three key areas ? program completion, exam pass rates and placement ? based on data from the Department of Labor, workforce offices and current partners. These efforts include enhancements to current programs, the launch of Experiential Learning Services and the newly adopted Apprenticeship program.  

About MedCerts:
MedCerts is a national online career training school pioneering the way students learn and employers hire. Focused on direct to consumer certifications in the healthcare and IT fields, the eLearning school helps students gain the skills and knowledge necessary to excel in new careers and deliver employers the right candidates to fit their organization. MedCerts provides certification and career training through HD-quality video-based instruction, virtual simulations, games and animations, and on-the-job training through Experiential Learning Solutions. Since 2009, the company has trained over 19,000 students in over 35 career programs and over 800 organizations are using or hiring these students. For more information, visit: www.medcerts.com

Media Contact
Jon-Eric Cornellier
Director of Marketing
734-469-5236
jecornellier@medcerts.com

SOURCE MedCerts


These press releases may also interest you

at 08:35
Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") , today announced the appointment of Michael Pine as Senior Vice President of Business Development and Strategy, effective September 21, 2020. Mr. Pine's responsibilities include developing...

at 08:33
Today, more than 100 patient groups across 38 countries launched the World Patients Alliance, an international advocacy coalition. The group seeks to give patients a seat at the healthcare policymaking table. "Too often, healthcare policy fails to...

at 08:30
Médunik Canada, a pharmaceutical company dedicated to improving the health and quality of life of Canadians with rare diseases, is extremely pleased to announce that its new orphan disease product Ruzurgi® (amifampridine) is now commercially...

at 08:30
A new smart-device application released today by the American Society of Nuclear Cardiology (ASNC) will make it easier for cardiovascular healthcare professionals to learn and implement the latest evidence-based imaging to improve patient care. The...

at 08:30
Drug development in neuromuscular disorders needs robust biomarker and clinical endpoints to study drug efficacy in early and late stage trials. Ultimately, functional decline and motor disability are the main clinical manifestations of neuromuscular...

at 08:30
Many drug development sponsors are interested in understanding how a digital biomarker strategy can improve patient-centricity their trial. However, may feel uncertain about where ? and sometimes even why ? to start. From concerns surrounding...



News published on 16 january 2020 at 13:28 and distributed by: